US govt gives $176m to Moderna for bird flu vaccine

July 4, 2024


The award from the Biomedical Advanced Research and Development Authority (BARDA) will be used to accelerate the development of pandemic flu vaccines, according to Moderna, and specifically “support late-stage development for an mRNA-based vaccine to enable the licensure of a pre-pandemic vaccine against H5 influenza virus.”

The agreement also includes additional options to respond to future public health threats, said the Cambridge, Massachusetts-based biotech.

Read More on Pharmaphorum